Seratrodast (AA-2414) - A novel thromboxane-A2 receptor antagonist

Cardiovascular Drug Reviews

Volumn 14, Issue 3, 1996, Pages 272-285

  Samara, Emil E ^a  

^a ABBOTT LABORATORIES   (United States)

Author keywords

AA 2414; Asthma; Seratrodast; TXA2

Indexed keywords

15 HYDROXY 11ALPHA,9ALPHA EPOXYMETHANOPROSTA 5,13 DIENOIC ACID; SERATRODAST; THROMBOXANE A2 RECEPTOR BLOCKING AGENT;

ARTERY THROMBOSIS; ASTHMA; CLINICAL TRIAL; COMPETITIVE INHIBITION; DOG; DRUG MARKETING; ENDOTHELIUM LESION; GUINEA PIG; HUMAN; LUNG PARENCHYMA; NONHUMAN; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; RABBIT; REVIEW; SAPHENOUS VEIN; SIDE EFFECT; SMOOTH MUSCLE CONTRACTION; TRACHEA;

EID: 0029830606     PISSN: 08975957     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1527-3466.1996.tb00231.x     Document Type: Review

References (38)

1. Ashida Y, Matsumoto T, Kuriki H, Shiraishi M, Kato K, Terao S. A novel anti-asthmatic quinone derivative, AA-2414, with a potent antagonistic activity against a variety of spasmogenic prostanoids. Prostaglandins 1989;38:91-112.
2. 2 receptor antagonist on experimental allergic asthma. Jpn Pharmacol Ther (suppl. 7) 1993;21:245-254.
3. Chiba S, Mikoda T, Mizutani M, Yamamote KI. Acute toxicity study of AA-2414 in mice and rats. Jpn Pharmacol Ther (Suppl. 7) 1993;21:5-12.
4. Fitzgerald DJ, Roy L, Catella F, FitzGerald GA. Platelet activation in unstable coronary disease. N Engl J Med 1986;315:983-989.
5. 2 receptor antagonist (AA-2414) on bronchial hyperresponsiveness to methacholine in subjects with asthma. J Allergy Clin Immunol 1991;87:23-27.
6. Hashizume M, Kurokawa D, Nishii S, Yoshioka F, Hada S, Yasunaga K. Clinical study on the inhibitory effect of AA-2414 on platelet function in asthmatic patients. Jpn J Aller 1990;39:509-519.
7. 2 receptor antagonist - repeated-dose study at 160 mg once daily for 7 days. Clin Pharmacol (Suppl. 8) 1993;9:41-55.
8. Hitotsumachi S, Kimura Y, Nakajima Y, Kikuchi Y. Mutagenicity study of AA-2414 - Micronucleus test in mice. Jpn Pharmacol Ther (Suppl. 7) 1993;21:197-199
9. Horiuchi K, Kurata K, Horinouchi A, Kondo M, Aono M, Nonoyama T. Fifty-two-week oral toxicity study of AA-2414 in beagle dogs. Jpn Pharmacol Ther (Suppl. 7) 1993;21:117-142.
10. 2-receptor antagonist AA-2414 in normal subjects: Population analysis. Clin Pharmacol Ther 1994;55:441-450.
11. 2 prostaglandin endoperoxide receptor in platelets and blood vessels. Jpn J Pharmacol 1990;52:35-43.
12. 2 in rabbit arterial thrombosis induced by endothelial damage. Thrombosis Research 1990,59:195-205.
13. 2 receptor antagonist, in rats, dogs, and monkeys. Jpn Pharmacol Ther (Suppl. 7) 1993;21:229-243.
14. 2 receptor by an anti-asthmatic agent AA-2414. Biol Pharm Bull 1994;17:383-385.
15. 2 receptor antagonist (AA-2414) in ascaris suum-allergic dogs. Prostaglandins 1993;46:301-318.
16. Matsumoto T, Ashida Y, Tsukuda R. Pharmacological modulation of immediate and late airway response and leukocyte infiltration in guinea pigs. J Pharmacol Exp Ther 1994;269:1236-1244.
17. 2 receptor antagonist, in rats, guinea-pigs, dogs, and monkeys. Jpn Pharmacol Ther (Suppl 7) 1993;21:201-228.
18. 2 receptor antagonists (S-1452, AA-2414, and ONO-3708) on the increase in pulmonary pressure caused by Forssman anaphylaxis in guinea pigs. Prostaglandins, Leukotrienes, and Essential Fatty Acids 1992; 45:233-238.
19. Nakai Y, Tagami M, Inoue S. Antigenicity of AA-2414 in guinea pigs and mice. Jpn Pharmacol Ther (Suppl. 7) 1993;21:185-190.
20. Nakatsu T, Kanamori H, Yoshizaki H. Teratological study of AA-2414 in rabbits. Jpn Pharmacol Ther (Suppl. 7) 1993;21:159-165.
21. Nonoyama T, Imai R-E, Kondo M, Hayashi S-M, Nakai Y, Shikata M. Fifty-two-week dietary toxicity study of AA-2414 in rats. Jpn Pharmacol Ther (Suppl. 7) 1993;21:101-116.
22. 2 production in patients with systemic lupus erythematosus. J Clin Invest 1985;76:1011-1018.
23. Reilly IA, Roy L, FitzGerald GA. Biosynthesis of thromboxane in patients with systemic sclerosis and Raynaud's phenomenon. Br Med J 1986;292:1037-1039.
24. Reines HD, Halushka PV, Cook JA, Wise WC, Rambo W Plasma thromboxane concentrations are raised in patients dying with septic shock. Lancet 1982;2:174-175.
25. Sakamoto Y, Yamamoto KS, Kikuchi Y, Hitotsumachi S. Mutagenicity study of AA-2414 - Reversion test in bacteria. Jpn Pharmacol Ther (Suppl. 7) 1993;21:191-196.
26. Samara E, Qian J, Locke CS, Granneman R, Dean R, Killian A. Single-dose and steady-state pharmacokinetics of seratrodast in healthy male and female volunteers. Pharmac Res (Suppl. 9) 1996;13:
27. Samara E, Granneman R, Locke CS, Dean R, Killian A. Pharmacokinetics and pharmacodynamics of seratrodast in patients with moderate asthma. Clin Pharmacol Ther 1996;2:208.
28. 2/endoperoxide receptors mediate chohnergic constriction of rabbit lung microvessels J Appl Physiol 1992;72:1179-1185.
29. Shiraishi M, Kato K, Terao S, Ashida V, Terashita Z, Kito G. Quinones. 4. Novel eicosanoid antagonists: Synthesis and pharmacological evaluation. J Med Chem 1989;32:2214-2221.
30. 4 in humans. Am Rev Respir Dis 1990;141:1441.
31. Sugitani T, Nakatsu T, Kumada S, Yoshizaki H, Kanamori H, Takatani O Reproduction study of AA-2414 in rats. Jpn Pharmacol Ther (Suppl 7) 1993;21.143-158.
32. Sugitani T, Takatani O, Kanamori H, Nakatsu T, Ooshima Y, Yoshizaki H. Peri- and post-natal study of AA-2414 in rats. Jpn Pharmacol Ther (Suppl. 7) 1993;21.167-184
33. Suzuki T, Naeshiro I, Horiuchi K, Miyajima H. Thirteen-week oral toxicity study of AA-2414 in beagle dogs. Jpn Pharmacol Ther (Suppl. 7) 1993;21:33-66.
34. Suzuki T, Orita S, Ito T, Naeshiro I, Sato S. Four-week oral toxicity study of AA-2414 in cynomolgus monkeys. Jpn Pharmacol Ther (Suppl. 7) 1993;21:67-100.
35. Suzuki T, Naeshiro I, Sato S, Miyajima H. Thirteen-week oral toxicity study of AA-2414 in rats. Jpn Pharmacol Ther (Suppl. 7) 1993;21:13-32.
36. 2 biosynthesis in acute asthma and after antigen challenge. Am Rev Respir Dis 1991;143:119.
37. Terao S. Quinone derivatives: Synthesis and structure-activity relations of a novel class of eicosanoid antagonists, AA-2414, and it analogs. Advances in Prostaglandin, Thromboxane, and Leukotriene Research 1989;19:651-654.
38. Wenzel SE, Westcott JY, Smith HR, Larsen GL. Spectrum of prostanoid release after bronchoalveolar allergen challenge in atopic asthmatics and in control groups. Am Rev Respir Dis 1989;139:450.